GUARDANT HEALTH INC (GH:NASDAQ)
$155 -7.96 (-4.8846%)
Analysed GUARDANT HEALTH INC (GH:NASDAQ) News Sources
Guardant Health (GH) Stock May Look Fully Valued Following Shield Coverage News
03-07-2026
yahoo.com
Guardant Health stock surges on colon cancer blood test news
05-07-2026
thestreet.com
Planet Labs Upgraded, Royal Caribbean Downgraded: Updated Rankings on Top Blue-Chip Stocks
06-07-2026
yahoo.com
UnitedHealth Group (UNH) Opens Shield Blood Test Coverage For Adults 45 And Older
07-07-2026
yahoo.com
Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
09-07-2026
yahoo.com
The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High
09-07-2026
yahoo.com
Cancer Blood Screen SPAC Merger Is Delayed by Test’s Results
09-07-2026
yahoo.com
Will Expanded Coverage of Guardant’s Shield Test Reshape UnitedHealth Group’s (UNH) Preventive Care Narrative?
13-07-2026
yahoo.com
Freenome colorectal cancer test data improve on earlier results
13-07-2026
medtechdive.com
Alamar Hits A High Note On Alzheimer's Buzz
13-07-2026
trefis.com
What is the current price of GUARDANT HEALTH INC (GH:NASDAQ)?
The current price of GUARDANT HEALTH INC (GH:NASDAQ) is $155.
GUARDANT HEALTH INC (GH:NASDAQ) absolute price change since previous trading day?
The absolute price change of GUARDANT HEALTH INC (GH:NASDAQ) since the previous trading day is $-7.96.
GUARDANT HEALTH INC (GH:NASDAQ) percentage price change since previous trading day?
The percentage price change of GUARDANT HEALTH INC (GH:NASDAQ) since the previous trading day is -4.8846%.
What is the most recent average sentiment score for GUARDANT HEALTH INC (GH:NASDAQ)?
The most recent average sentiment score for GUARDANT HEALTH INC (GH:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for GUARDANT HEALTH INC (GH:NASDAQ)?
The most recent sentiment for GUARDANT HEALTH INC (GH:NASDAQ) is .
SEC-8K** Filing Available For GUARDANT HEALTH INC (GH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.